FIGS, Inc. 2026 Q2 Earnings Call
Review the key takeaways and the transcript of this earnings call.
- FIGS reported second quarter fiscal 2026 net revenues of $197 million, a 29% year-over-year increase, surpassing their outlook and marking the third consecutive quarter with over 25% growth.
- Active customers grew 13% to 3.1 million, average order value reached a record $127, and net revenues per active customer hit an all-time high of $229.
- Adjusted EBITDA margin surged to 18.6%, driven by increased full price selling, improved returns, and expense leverage.
- International net revenues grew 67% to $37.9 million, with expansion into 85 international markets including 27 new ones.
- Non-scrub wear sales increased 40%, now representing nearly 20% of total net revenues.
- The company acquired V Coterie, a provider of pins, jewelry, charms, and accessories for healthcare professionals, to expand product offerings and deepen customer loyalty.
- Share repurchases totaled approximately $24 million in Q2, with a new $100 million authorization increasing total repurchase capacity to $119 million.
- Gross margin improved by 820 basis points to 75.2%, including a $15.4 million tariff refund benefit.
- Net income was $28.4 million or $0.15 diluted EPS, compared to $7.1 million or $0.04 diluted EPS in the prior year quarter.
- Inventory decreased 12% year-over-year to $119.6 million, with expectations for continued double-digit declines in Q3 due to supplier transitions.
- The company is managing supply chain disruptions from a U.S. Customs withhold release order affecting imports from Jordan by leveraging other suppliers and expediting production.
STOCKNOW INSIGHTS
Continue with outlook and guidance.
Log in to unlock executive comments and Q&A highlights.
Log in for the full summaryStockNow uses AI to translate and summarize earnings calls. Accuracy and completeness are not guaranteed.
Transcript
Preview the first fifteen paragraphs, organized by speaker.
Hello, everyone. Thank you for joining us, and welcome to the FIGS's second quarter fiscal 2026 earnings conference call. After today's prepared remarks, we will host a question and answer session. If you would like to ask a question, please press star one to raise your hand. To withdraw your question, press star one again. I will now hand the conference over to Tom Shaw, Senior Vice President of Investor Relations. Please go ahead. Good afternoon.
Thank you for joining us to discuss FIGS's second quarter 2026 results, which we released this afternoon and can be found in our earnings press release and in the shareholder presentation posted to our investor relations website at ir.wearfigs.com. Presenting on today's call are Trina Spear, our Co-founder and Chief Executive Officer, and Sarah Oughtred, our Chief Financial Officer. As a reminder, remarks on this call that do not concern past events are forward-looking statements. These may include predictions, expectations, or estimates, including about future financial performance, market opportunity, or business plans. Forward-looking statements involve risk and uncertainties, and actual results could differ materially. These and other risks are discussed in our SEC filings, including in the 10-Q we filed today. Do not place undue reliance on forward-looking statements, which speak only as of today and which we undertake no obligation to update.
Finally, we will discuss certain non-GAAP metrics and key performance indicators which we believe are useful supplemental measures for understanding our business. Definitions and reconciliations of these non-GAAP measures to their most comparable GAAP measures are included in our shareholder presentation. Now, I would like to turn the call over to Trina.
Thanks, Tom. Good afternoon, everyone. Thank you for joining us today. FIGS's strong, broad-based momentum continued in Q2, highlighting the sustainability of our success and our truly unique positioning. Net revenues grew 29% to $197 million, beating our outlook and marking our third straight quarter with 25%+ growth. Notably, this is the strongest sustained stretch of growth we have seen since 2021. What is most exciting is that our growth is coming from across our business rather than from just one part of it. We are seeing tremendous traction across the board, our channels, product categories, geographies, and customer cohorts, driving a number of record highs for the brand. As examples, we have never sold more scrub wear in a single quarter than we did in Q2, and our three market expansion opportunities, international teams, and community hubs each achieved new highs.
Our strength is seen in the metrics. Active customer growth surged 13% to 3.1 million. AOV hit its own record of $127, and purchase frequency continued to increase. This powerful combination drove net revenues per active customer to an all-time high for the brand of $229, surpassing even our COVID era peak of $227. This success is a manifestation of everything we've been outlining in recent quarters and gives us even greater conviction in the growth opportunities that lie ahead. Just as impressive is our progress on profitability. Excluding the prior year portion of tariff refunds, adjusted EBITDA margin surged to 18.6%. Underlying that performance, our strong margin expansion was driven by efforts to increase full price selling and improve returns, both strong indicators of brand health, as well as overall expense leverage, given our incredible top-line momentum.
Finally, we have not only accelerated our share buyback efforts during the quarter, but just announced a new $100 million authorization, demonstrating the confidence we have in our brand, our strategy, and the opportunity in front of us. With this strength, I want to take a moment to reiterate why we believe we are winning, because I think it is important context for everything that follows. It starts with brand differentiation. Technically advanced products are non-negotiable for us, and we are extending our premium positioning and bringing even more impact and relevance to our product lineup, from scrubs to the full layering system, to solve needs of healthcare professionals. What truly sets FIGS apart is our unique ability to drive connection and be part of the cultural conversation in healthcare in a way no one else is.
This combination, product and storytelling, is incredibly powerful and hard to replicate. Second, we are building a durable foundation for growth, supported by sustained investments across our team, technology, and customer acquisition. We have talked a lot about our growing sophistication of how we bring the brand and product to life, efforts designed for more than driving performance in a single year. They are about building the resiliency and agility to continue delivering elevated performance across top line, profitability, and shareholder returns over the long run. Third, we are serving the best industry in the world. Healthcare touches everyone. Those needs are only growing as the demands of the profession are compounded by an aging population and growing focus on wellness.
Healthcare and social assistance is projected to have the largest job growth and be the fastest-growing industry over the next decade. We see this demand in our data. With an average of over 50,000 new jobs coming into the industry each month this year, the broader healthcare industry is serving as a powerful driver of overall job creation in the United States. These macro tailwinds, combined with the strong fundamentals of healthcare apparel, make this industry highly attractive. Unlike other apparel companies, we do not sell product that's driven by fad or prevents inventory risk. We sell non-discretionary and replenishment-driven uniforms that do not go out of style and that healthcare professionals need all year round. Because so many of them work in densely packed institutions wearing FIGS as a walking billboard, we benefit from a word-of-mouth dynamic that is very unique.
Before I move on, I want to provide a quick update on our supply chain.
I used the word resilience earlier in my remarks. It applies here, too. U.S. Customs and Border Protection recently issued a Withhold Release Order that currently prevents us from importing product into the United States from our partner in Jordan. Through COVID and the disruption in the Middle East, facing supply chain challenges is not new to us. We have always been able to manage through them due to the strength and flexibility of the supply chain we've built. That remains true today. Our team is cross-functionally adapting our planning to mitigate disruption in the second half of the year. This includes leveraging capacity with our other strong existing partners and expediting their production. As a reminder, our high volume, low SKU count footprint is a powerful differentiator that makes us highly attractive to the world's best suppliers.
Most importantly, even with this challenge, we are able to raise our top and bottom line targets. We have not only passed through the upside of our Q2 results, we've also layered in increased expectations for the balance of the year. This is exactly the kind of agility that spotlights the strength of the foundation we have built. It positions us for long-term execution in delivering great product to our community. Let me share some of the progress we are most excited about across product, brand, and market expansion. Starting with product, we are winning at the intersection of style, color, fabric, and fit. On style, we are evolving choice for healthcare professionals, complementing our successful core styles with modern looks that combine functionality, design, and comfort. Our scrub pants are a great example.
Wider leg solutions continue to resonate strongly. We're continuing to bring newness in this area, including new waistband options that debut this quarter. This strategy reflects our unique merchandising flywheel in action. We launch limited edition options that generate excitement and a quick sell-through while driving in greater interest in the core that represents the majority of our business. Color is always important at FIGS. It is woven into the DNA of our brand across both core and limited edition styles. We are always listening to feedback, analyzing trends, and responding quickly. Espresso is a great example. To say that our community was clamoring for this color was an understatement. We heard them. We responded with two separate launch moments this year, including a product drop just last week that sold out quickly.
We have used color to tap into cultural moments, incorporating it into our Star Wars collaboration in Q2, and into our new collaboration with Marvel's Spider-Man, which launched this quarter timed with the movie's release, and was a huge hit. On fabrication, we remain focused on delivering across the full spectrum of use cases, complementing our hallmark FIONx with FORMx, and now our new FiberX. FORMx continues to resonate and grow as a complement to our core offering, and we're super excited to build on the FiberX story in the weeks ahead. Wrapping all of this together is fit. All new products are aligned with the fit work we have been driving the past few years, and we continue to be encouraged by the gains we are seeing through lower returns and positive customer feedback. On non-scrub wear, we remain focused on building out our layering system.
We are winning here. 40% growth in the quarter was the highest we've seen in nearly 4 years. Non-scrub wear now represents nearly 20% of our business, and we believe it can mix even higher over time as we build out key areas, including under scrubs, lab coats, outerwear, footwear, medical grade compression socks, and jewelry. Healthcare professionals may wear a uniform, but they're looking for ways to personalize and accessorize their look. This brings me to something we're incredibly excited to announce. As you may have seen from our recent social posts, we have acquired V Coterie. A longtime partner of ours on pins, V Coterie brings a broad range of pins, jewelry, charms, and accessories dedicated to the healthcare community. These are not just any kinds of accessories.
V Coterie's founder, Lynna Van Merkey, who we are excited to announce is now part of FIGS, is a former dentist and an incredible entrepreneur who has creatively married jewelry and healthcare in a way no one else has. While V Coterie is immaterial from a purchase standpoint, our community loves these products, and we believe this positions us to unlock meaningful growth opportunities in this category going forward. Ultimately, this is a great example of how we drive a greater share of wallet and expand consideration for our brand. On the brand side, we had a series of powerful moments throughout the quarter, and what I want to highlight most is how we are threading our support of this community across multiple efforts in real, impactful ways.
FULL TRANSCRIPT
Continue the full translated transcript in StockNow.
Log in to unlock every statement, the English original, and speaker-by-speaker history.
Log in for the full transcriptCall participants
12 people spoke on this call — only 2 are shown here.
PARTICIPANT LIST
View participant details in StockNow.
Log in to see executives and analysts, their roles, and complete speaking history.
Log in to view all participantsKeep exploring
